These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23621605)

  • 1. Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.
    Nduom EK; Yang C; Merrill MJ; Zhuang Z; Lonser RR
    J Neurosurg; 2013 Aug; 119(2):427-33. PubMed ID: 23621605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the blood brain barrier in pediatric central nervous system neoplasms.
    Hong CS; Ho W; Piazza MG; Ray-Chaudhury A; Zhuang Z; Heiss JD
    J Interdiscip Histopathol; 2016; 4(2):29-33. PubMed ID: 27917302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological study on malignant glioma--with special reference to GFAP].
    Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
    No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphometrical analysis of GFAP-positive cells in human astrocytomas.
    Yoshii Y; Narushima K; Tsurushima H; Yanaka K; Hyodo A; Nose T; Sugiyama K; Sakamura S
    Neurol Med Chir (Tokyo); 1992 Jul; 32(8):554-8. PubMed ID: 1383844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucose transporter and blood-brain barrier of human brain tumors.
    Guerin C; Laterra J; Hruban RH; Brem H; Drewes LR; Goldstein GW
    Ann Neurol; 1990 Dec; 28(6):758-65. PubMed ID: 2178329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.
    Leiss L; Mega A; Olsson Bontell T; Nistér M; Smits A; Corvigno S; Rahman MA; Enger PØ; Miletic H; Östman A
    Glia; 2020 May; 68(5):979-988. PubMed ID: 31769546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system.
    Tascos NA; Parr J; Gonatas NK
    Hum Pathol; 1982 May; 13(5):454-8. PubMed ID: 6281168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
    Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
    J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cathepsin D in human astrocytic neoplasias.
    Warich M; von Bossanyi P; Dietzmann K
    Gen Diagn Pathol; 1995 Oct; 141(2):93-6. PubMed ID: 8548599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of emmprin expression in vascular endothelial cells with blood-brain-barrier function: a study using magnetic resonance imaging enhanced by Gd-DTPA and immunohistochemistry in brain tumors.
    Sameshima T; Nabeshima K; Toole BP; Inoue T; Yokogami K; Nakano S; Ohi T; Wakisaka S
    Virchows Arch; 2003 Jun; 442(6):577-84. PubMed ID: 12719975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of neuronal markers, NFP and GFAP, in malignant astrocytoma.
    Hashemi F; Naderian M; Kadivar M; Nilipour Y; Gheytanchi E
    Asian Pac J Cancer Prev; 2014; 15(15):6315-9. PubMed ID: 25124617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms.
    Kharbanda K; Sarkar C; Dinda AK; Karak AK; Mathur M; Roy S
    Acta Oncol; 1993; 32(3):301-6. PubMed ID: 8391834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
    Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
    Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytokeratins in gliomas.
    Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal relationship between aquaporin-4 and glial fibrillary acidic protein in cerebellum of neonate and adult rats administered a BBB disrupting spider venom.
    Stavale LM; Soares ES; Mendonça MC; Irazusta SP; da Cruz Höfling MA
    Toxicon; 2013 May; 66():37-46. PubMed ID: 23419593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. J1-31 protein expression in astrocytes and astrocytomas.
    Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
    Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.